Regulations.gov document
2017001143 - Jarrow Formulas, Inc. - Jarrow Formulas® Preg-Natal® Dietary - provides…
Other · FDA-2017-S-0024 · posted Jun 19, 2018
Key facts
| Document ID | FDA-2017-S-0024-0968 |
|---|---|
| Title | 2017001143 - Jarrow Formulas, Inc. - Jarrow Formulas® Preg-Natal® Dietary - provides docosahexaenoic acid (DHA), the predominant fatty acid in the brain, nervous system and retina, Choline is important for neurological development of the fetus |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2017-S-0024 |
| Posted | Jun 19, 2018 |
| Comment period opens | Jun 19, 2018 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: